Lundbeck is a global pharmaceutical company dedicated to improving the lives of people living with brain diseases. Headquartered in Denmark and founded in 1915, Lundbeck focuses exclusively on disorders of the brain, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, migraine, and epilepsy. The company's mission is to be at the forefront of neuroscience research, discovering and delivering innovative treatments that make a meaningful difference for patients and their families.